Quimioterapia de elección tras hormonoterapia en cáncer de mama metastásico - page 4

Gonzalez et al CTO 2016

Advanced HR positive BC landscape: HT vs CT

A definition for aggressive disease in patients with HER-2 negative MBC: an expert consensus of SEOM

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1,2,3 5,6,7,8,9,10,11,12,13,14,...36